84
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Impact of Opioid Receptor Gene Polymorphism on Fentanyl and Alfentanil’s Analgesic Effects in the Pediatric Perioperative Period

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , , & ORCID Icon show all
Pages 41-49 | Received 03 Oct 2023, Accepted 18 Jan 2024, Published online: 29 Jan 2024
 

Abstract

Introduction

The polymorphism of the gene coding mu-opioid receptor (OPRM1) is one of the factors contributing to the variability in the response to opioid analgesics in children. The goal of this study is to investigate its role in association with postoperative acute pain in children of various ages.

Methods

This prospective study analyzed 110 pediatric patients, after plastic or orthopedic surgery, who were genotyped and randomly assigned to receive fentanyl or alfentanil. Postoperative pain was rated using Numerical Rating Scale (0–10). All the patients were genotyped forOPRM1 118A>G (rs1799971) gene polymorphism.

Results

School children under the age of 11 with the OPRM1 AA genotype were shown to have a higher BMI (p<0.05). Children over the age of 12 carrying G allele OPRM1, had increased postoperative pain sensitivity and intensity (3.28±1.95 vs 4.91±2.17; p<0.05), as compared to AA allele carriers.

Discussion

OPRM1 118A>G polymorphism may explain the variation in the perception of postoperative pain in children over the age of 12 and may be a useful predictor for adjusting the dose of analgesics, but the dose is relative to the patient’s needs regardless of his genetic characteristics. In younger children, carriers of polymorphic OPRM1 118G allele may be protected from obesity, due to diminished MOP expression.

Acknowledgments

This research was supported by the Internal Project of the Faculty of Medicine, University of Nis, Republic of Serbia (int-MF-42/2020-23).

Disclosure

The authors report no conflicts of interest in this work.